Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions

Rajesh Jha,Sara Lopez-Trevino,Haritha R. Kankanamalage,Jay C. Jha

DOI: https://doi.org/10.3390/biomedicines12051098

IF: 4.757

2024-05-16

Biomedicines

Abstract:Diabetic kidney disease (DKD) is a major microvascular complication of both type 1 and type 2 diabetes. DKD is characterised by injury to both glomerular and tubular compartments, leading to kidney dysfunction over time. It is one of the most common causes of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Persistent high blood glucose levels can damage the small blood vessels in the kidneys, impairing their ability to filter waste and fluids from the blood effectively. Other factors like high blood pressure (hypertension), genetics, and lifestyle habits can also contribute to the development and progression of DKD. The key features of renal complications of diabetes include morphological and functional alterations to renal glomeruli and tubules leading to mesangial expansion, glomerulosclerosis, homogenous thickening of the glomerular basement membrane (GBM), albuminuria, tubulointerstitial fibrosis and progressive decline in renal function. In advanced stages, DKD may require treatments such as dialysis or kidney transplant to sustain life. Therefore, early detection and proactive management of diabetes and its complications are crucial in preventing DKD and preserving kidney function.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The problems that this paper attempts to solve are the pathophysiological mechanisms, biomarkers, and treatment interventions of diabetic kidney disease (DKD). Specifically:

1. **Pathophysiological mechanisms**:
- The paper elaborately explores the multi - factor pathophysiological process of diabetic kidney disease, including multiple pathological pathways caused by hyperglycemia, such as hemodynamic changes, metabolic abnormalities, inflammatory responses, fibrosis, and oxidative stress. These pathways interact in different parts of the kidney (such as glomeruli, blood vessels, renal tubules, and interstitium) and jointly promote the development of diabetic kidney disease.
- It particularly emphasizes how hyperglycemia leads to glomerular hyperfiltration by increasing intraglomerular pressure and dilating afferent arterioles, thereby causing kidney injury. In addition, it also discusses the central role of oxidative stress in the occurrence and development of diabetic kidney disease, and the importance of NADPH oxidase in generating reactive oxygen species (ROS).

2. **Biomarkers**:
- The paper reviews the biomarkers used for diagnosing and monitoring the progression of diabetic kidney disease, including albuminuria, glycated albumin, transferrin, adiponectin, ceruloplasmin, laminin fragments, podocyte number and its specific proteins, neutrophil gelatinase - associated lipocalin (NGAL), N - acetyl - β - D - glucosaminidase (NAG), kidney injury molecule - 1 (KIM - 1), α1 - microglobulin and β2 - microglobulin, fatty acid - binding protein, retinol - binding protein 4 (RBP4), pro - inflammatory markers, oxidative stress markers, etc.
- These biomarkers are not only helpful for early detection of diabetic kidney disease but also can assess the severity and progression of the disease and guide clinical treatment decisions.

3. **Treatment interventions**:
- The paper reviews the current methods used for treating diabetic kidney disease, including renin - angiotensin system blockers (such as ACE inhibitors and angiotensin receptor blockers), mineralocorticoid receptor blockers, and sodium - glucose cotransporter 2 (SGLT2) inhibitors, etc.
- Although these treatment methods have achieved certain effects, there is still no radical cure for diabetic kidney disease, and many patients eventually develop end - stage renal disease (ESRD) and require dialysis or kidney transplantation. Therefore, the paper emphasizes the importance of developing more effective treatment strategies and early diagnosis.

In conclusion, this paper aims to comprehensively overview the pathophysiological mechanisms, biomarkers, and treatment interventions of diabetic kidney disease, in order to provide the latest scientific basis for clinicians and researchers and promote the prevention, early diagnosis, and effective treatment of diabetic kidney disease.